Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2107)	1/10/2008 5:30:38 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

ARWR wasn't helped by yesterday's presentation at the 10th Annual Needham Growth Stock Conference in N.Y., the stock was down 2.66% with volume above its ADV & the stock has continue to drift down AHs. bigcharts.marketwatch.com It seems that the stock is going to retest support at the $3.11 level (the L of Dec18). It has already closed its Dec20 UG. bigcharts.marketwatch.com Will see if it reports on its PI of IT-101 this month as I mentioned back in Nov., was expected in January. Message 24038378 ARWR has persistent losses, but has two consecutive Qs of triple digit improvements on revenues & with some good news & the short ratio of > 16x the ADV, the stock can double this Yr.I will continue to hold a small position, but won't add until we have a better picture on the general market's condition. It seems that not only we aren't going to have the January Effect this Yr., but we won't have the benefit of a Presidential Election either.<g> bigcharts.marketwatch.com Bernard